Why is Chemcrux Enterprises Ltd falling/rising?

Recent Price Movements and Market Performance

Chemcrux Enterprises hit a fresh 52-week low of ₹93 during intraday trading on 20 January, marking a 7.83% fall from previous levels. The stock underperformed its sector by 3.06% on the day, with the weighted average price indicating that a larger volume of shares traded closer to the day’s low. This suggests selling pressure dominated throughout the session. Furthermore, the stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a bearish trend and weak investor sentiment.

Investor participation has also waned, with delivery volumes on 19 January falling by nearly 26% compared to the five-day average. Despite adequate liquidity to support trading, the reduced investor interest compounds the downward momentum.

Long-Term Underperformance and Financial Weakness

Over the past year, Chemcrux Enterprises has delivered a return of -42.79%, starkly contrasting with the Sensex’s positive 6.63% gain. The stock’s three-year and five-year returns further highlight its struggles, with losses of 73.46% over three years and a modest 34.40% gain over five years, both significantly lagging the Sensex’s respective 35.56% and 65.05% rises. This consistent underperformance against major benchmarks and the BSE500 index over multiple annual periods underscores the company’s challenges in generating shareholder value.

Financially, the company’s net sales have declined at an annualised rate of 13.89% over the last five years, while operating profit has contracted by 42.95% in the same period. The latest half-year results reveal a flat performance, with profit before tax excluding other income falling by 117.69% to a loss of ₹0.23 crore. Return on capital employed (ROCE) remains subdued at 4.2%, with the half-year ROCE at a low 6.37%, indicating limited efficiency in generating returns from capital invested.

Despite these challenges, Chemcrux maintains a relatively strong debt servicing ability, evidenced by a low Debt to EBITDA ratio of 1.30 times. The stock trades at a discount relative to peers’ historical valuations, with an enterprise value to capital employed ratio of 1.7, suggesting some valuation support. However, this has not translated into positive price momentum, as profits have fallen by 56.2% over the past year.

Investor Outlook and Conclusion

The persistent decline in Chemcrux Enterprises’ share price is primarily driven by its poor long-term growth trajectory, weak profitability, and consistent underperformance relative to market indices. The company’s flat recent results and low returns on capital further dampen investor confidence. While the firm’s low leverage and discounted valuation offer some positives, these factors have not been sufficient to arrest the downward trend.

Given the stock’s ongoing struggles, including falling sales, shrinking profits, and diminished investor participation, market participants appear cautious. The current price action reflects a lack of conviction in the company’s near-term recovery prospects, leading to continued selling pressure and a slide to new lows.

Investors seeking exposure to the specialty chemicals sector may wish to consider alternative opportunities with stronger financial metrics and more consistent performance records.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →